We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$140B
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.3%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$38.5B
AUM Growth
+$4.48B
(+13%)
Cap. Flow
+$4.55B
Cap. Flow
% of AUM
11.82%
Top 10 Holdings %
Top 10 Hldgs %
13.89%
Holding
2,364
New
149
Increased
1,180
Reduced
895
Closed
134
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$275M |
| 2 |
First Trust Health Care AlphaDEX Fund
FXH
|
+$221M |
| 3 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$193M |
| 4 |
First Trust Consumer Staples AlphaDEX Fund
FXG
|
+$188M |
| 5 |
First Trust Consumer Discretionary AlphaDEX Fund
FXD
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$230M |
| 2 |
Spectrum Brands
SPB
|
+$81.6M |
| 3 |
Chevron
CVX
|
+$79.8M |
| 4 |
Pfizer
PFE
|
+$66.7M |
| 5 |
K
Kellanova
K
|
+$63.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.09% |
| 2 | Consumer Discretionary | 10.38% |
| 3 | Technology | 9.81% |
| 4 | Consumer Staples | 7.93% |
| 5 | Communication Services | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
CF Industries
CF
$19.2B
| $29.2M | 0.08% |
454,564
-18,796
| -4% | -$1.14M |
|
302
Cinemark Holdings
CNK
$3.82B
| $28.9M | 0.08% |
+719,931
| New | +$30M |
|
303
Amphenol
APH
$188B
| $28.8M | 0.07% |
1,988,872
+858,724
| +76% | +$12.3M |
|
|
BHI
304
DELISTED
Baker Hughes
BHI
| $28.7M | 0.07% |
464,537
-72,481
| -13% | -$4.74M |
|
305
PNC Financial Services
PNC
$100B
| $28.4M | 0.07% |
296,724
+35,582
| +14% | +$3.36M |
|
306
Dover
DOV
$27.2B
| $28.4M | 0.07% |
500,255
+11,894
| +2% | +$708K |
|
|
QEP
307
DELISTED
QEP RESOURCES, INC.
QEP
| $28.4M | 0.07% |
1,532,100
+29,303
| +2% | +$601K |
|
|
SWN
308
DELISTED
Southwestern Energy Company
SWN
| $28.4M | 0.07% |
1,247,326
+178,688
| +17% | +$4.58M |
|
309
Everest Group
EG
$15.2B
| $28.3M | 0.07% |
155,379
+20,528
| +15% | +$3.74M |
|
|
FISV
310
Fiserv Inc
FISV
$27.2B
| $28.2M | 0.07% |
681,564
+185,964
| +38% | +$7.48M |
|
311
Snap-on
SNA
$20.9B
| $28.2M | 0.07% |
177,119
+26,705
| +18% | +$4.12M |
|
|
SGI
312
Somnigroup International
SGI
$15.1B
| $28.1M | 0.07% |
1,705,872
+1,211,188
| +245% | +$18.5M |
|
313
Bristol-Myers Squibb
BMY
$127B
| $28M | 0.07% |
420,502
+63,169
| +18% | +$4.16M |
|
314
Herbalife
HLF
$1.23B
| $27.8M | 0.07% |
+1,009,274
| New | +$24.4M |
|
315
DuPont de Nemours
DD
$18.6B
| $27.8M | 0.07% |
214,421
-656
| -0.3% | -$85K |
|
316
Wells Fargo
WFC
$261B
| $27.7M | 0.07% |
492,874
+183,148
| +59% | +$10.2M |
|
317
Newmont
NEM
$99.5B
| $27.7M | 0.07% |
1,184,932
+919,424
| +346% | +$23M |
|
318
Assurant
AIZ
$13.7B
| $27.1M | 0.07% |
404,506
+76,518
| +23% | +$4.93M |
|
319
FedEx
FDX
$74.5B
| $27.1M | 0.07% |
158,958
+54,198
| +52% | +$9.43M |
|
320
Quanta Services
PWR
$93.9B
| $27.1M | 0.07% |
939,553
-336,675
| -26% | -$9.84M |
|
321
Progressive
PGR
$124B
| $27M | 0.07% |
971,334
+164,579
| +20% | +$4.49M |
|
322
Advance Auto Parts
AAP
$3.37B
| $26.9M | 0.07% |
168,982
-60,017
| -26% | -$9.17M |
|
323
First Solar
FSLR
$21.8B
| $26.7M | 0.07% |
568,977
-201,304
| -26% | -$11.2M |
|
324
Franklin Resources
BEN
$16.9B
| $26.7M | 0.07% |
544,585
+125,318
| +30% | +$6.43M |
|
|
TE
325
DELISTED
TECO ENERGY INC
TE
| $26.6M | 0.07% |
1,508,897
+147,555
| +11% | +$2.76M |
|
Similar funds
DAM
First Trust Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, First Trust Advisors held 2,364 positions worth $38.5B, up 13% from $34B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
First Trust Advisors deployed $4.55B of net new capital in Q2 2015, opening 149 new positions and adding to 1,180 existing holdings. Its largest new stake was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Chevron, an estimated $79.8M trimmed.
- First Trust Advisors's largest Q2 2015 buy was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
- First Trust Advisors added most to First Trust NYSE Arca Biotechnology Index Fund in Q2 2015, an estimated $275M increase.
- First Trust Advisors's biggest Q2 2015 reduction was Chevron, cutting an estimated $79.8M.
- First Trust Advisors fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $230M.
- First Trust Advisors's ten largest holdings make up 14% of its $38.5B portfolio in Q2 2015.
- First Trust Advisors opened 149 new positions and closed 134 in Q2 2015.
- First Trust Advisors's portfolio value rose 13% quarter-over-quarter to $38.5B.
Based on First Trust Advisors's 13F filing for Q2 2015, filed 4 Aug 2015.